The DOI matches its Crossref record; the references it cites are not checked yet.
Loss of hepatic Mboat7 leads to liver fibrosis
Open accessAbstract
Objective: The rs641738C>T variant located near the membrane-bound O-acyltransferase domain containing 7 (MBOAT7) locus is associated with fibrosis in liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, hepatitis B and C. We aim to understand the mechanism by which the rs641738C>T variant contributes to pathogenesis of NAFLD. Design: Mice with hepatocyte-specific deletion of MBOAT7 (Mboat7 Δhep) were generated and livers were characterised by histology, flow cytometry, qPCR, RNA sequencing and lipidomics. We analysed the association of rs641738C>T genotype with liver inflammation and fibrosis in 846 NAFLD patients and obtained genotype-specific liver lipidomes from 280 human biopsies. Results: Allelic imbalance analysis of heterozygous human liver samples pointed to lower expression of the MBOAT7 transcript on the rs641738C>T haplotype. Mboat7 Δhep mice showed spontaneous steatosis characterised by increased hepatic cholesterol ester content after 10 weeks. After 6 weeks on a high fat, methionine-low, choline-deficient diet, mice developed increased hepatic fibrosis as measured by picrosirius staining (p<0.05), hydroxyproline content (p<0.05) and transcriptomics, while the inflammatory cell populations and inflammatory mediators were minimally affected. In a human biopsied NAFLD cohort, MBOAT7 rs641738C>T was associated with fibrosis (p=0.004) independent of the presence of histological inflammation. Liver lipidomes of Mboat7 Δhep mice and human rs641738TT carriers with fibrosis showed increased total lysophosphatidylinositol levels. The altered lysophosphatidylinositol and phosphatidylinositol subspecies in MBOAT7 Δhep livers and human rs641738TT carriers were similar. Conclusion: Mboat7 deficiency in mice and human points to an inflammation-independent pathway of liver fibrosis that may be mediated by lipid signalling and a potentially targetable treatment option in NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, PNPLA3 and MBOAT7 variants also directly impact fibrogenic signalling in stellate cells,29,30”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“Additionally, after the initial discovery of Membrane Bound O-Acyltransferase Domain Containing 7 (MBOAT7) as a risk gene for alcohol-related cirrhosis, MBOAT7 allele rs641738 was subsequently verified as a risk factor for MASH (137-139).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 45 · Cited by 125
Metadata
- Authors
- Thangapandi, V. R., Knittelfelder, O., Brosch, M., Patsenker, E., Vvedenskaya, O., Buch, S., Hinz, S., Hendricks, A., Nati, M., Herrmann, A., Rekhade, D. R., Berg, T., Matz-Soja, M., Huse, K., Klipp, E., Pauling, J. K., Wodke, J. A., Miranda Ackerman, J., Bonin, M. V., Aigner, E., Datz, C., von Schönfels, W., Nehring, S., Zeissig, S., Röcken, C., Dahl, A., Chavakis, T., Stickel, F., Shevchenko, A., Schafmayer, C., Hampe, J., & Subramanian, P.
- Affiliations
- Center for Regenerative Therapies Dresden (DE)
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University Hospital Zurich (CH)
- University Hospital Schleswig-Holstein (DE)
- Technische Universität Dresden (DE)
- University Hospital Leipzig (DE)
- Division of Hepatology, Department of Oncology, Gastroenterology, Hepatology Pulmonology, and Infectious Diseases, University Hospital Leipzig, Leipzig, Sachsen, Germany
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Humboldt-Universität zu Berlin (DE)
- Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden, Sachsen, Germany
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Paracelsus Medical University (AT)
- University of Salzburg (AT)
- Department of Visceral and Thoracic Surgery, Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany
- Helmholtz Munich (DE)
- University of Rostock (DE)
- University Hospital Carl Gustav Carus (DE)
- Corresponding author
- Hampe, Jochen
- ORCID
- Knittelfelder, Oskar
- Brosch, Mario
- Patsenker, Eleonora
- Vvedenskaya, Olga
- Buch, Stephan
- Hinz, Sebastian
- Hendricks, Alexander
- Herrmann, Alexander
- Berg, Thomas
- Huse, Klaus
- Klipp, Edda
- Pauling, Josch K
- Bonin, Malte von
- Aigner, Elmar
- Datz, Christian
- Zeissig, Sebastian
- Röcken, Christoph
- Dahl, Andreas
- Chavakis, Triantafyllos
- Stickel, Felix
- Shevchenko, Andrej
- Schafmayer, Clemens
- Hampe, Jochen
- Subramanian, Pallavi
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2020-06-26
- Volume
- 70
- Issue
- 5
- Pages
- 940-950
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC8040158
- OpenAlex
- W3037761084
- Cited by
- 125
- References
- 45
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 16 · 2023: 27 · 2022: 23 · 2021: 18 · 2020: 7
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gut (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
- Site cant be reached (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Lipidomics and Informatics for Life Sciences (LIFS) grant Unit of the de.NBI Consortium
- Swiss National Funds
- ERC grant
- ERACOSysMed (Dynaflow) grant
- Bavarian State Ministry of Science and the Arts in the framework of the Centre Digitisation. Bavaria (ZD. B) to JP
- German Ministry of Research and Education (BmBF) through the Liver Systems Medicine (LiSyM) network grant
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- MBOAT7, liver fibrosis, non-alcoholic fatty liver disease, hepatocyte-specific deletion, hepatic steatosis, lysophosphatidylinositol, phosphatidylinositol, lipid signaling
- MeSH terms
- Acyltransferases, Adult, Aged, Animals, Biopsy, Disease Models, Animal, Female, Genotype, Haplotypes, Humans, Inflammation, Liver Cirrhosis, Male, Membrane Proteins, Mice, Inbred C57BL, Middle Aged, Disease Progression, Polymorphism, Single Nucleotide, Mice, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of hepatic Mboat7 leads to liver fibrosis. https://app.cochat.ai/papers/10.1136/gutjnl-2020-320853
- The paper
- Thangapandi, V. R., Knittelfelder, O., Brosch, M., Patsenker, E., Vvedenskaya, O., Buch, S., Hinz, S., Hendricks, A., Nati, M., Herrmann, A., Rekhade, D. R., Berg, T., Matz-Soja, M., Huse, K., Klipp, E., Pauling, J. K., Wodke, J. A., Miranda Ackerman, J., Bonin, M. V., . . . Subramanian, P. (2021). Loss of hepatic Mboat7 leads to liver fibrosis. Gut. https://doi.org/10.1136/gutjnl-2020-320853
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.